PROVIDER PROFILE · NPI 1275789877
Daniel KreutzM.D.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
7,421
Unique beneficiaries
—
Total services
162,301
Distinct HCPCS
57
Medicare payment
$2.7M
Peer benchmark
Total Medicare services vs. 71 Rheumatology providers in AZ — top quintile (cohort median 9,320).
PRESCRIBING · PART D · 2024
Total Rx claims
2,169
Beneficiaries
—
Total drug cost
$2.3M
Distinct drugs
25
Brand share
34.9%
Top prescribed drugs
Methotrexate Sodium481 claims
Hydroxychloroquine Sulfate344 claims
Prednisone302 claims
Duloxetine Hcl147 claims
Leflunomide118 claims
QUALITY · MIPS · 2024
Final MIPS score
99.2
Quality
0.0
Cost
47.8
Improvement activities
40.0
Promoting interop.
99.0
Payment adjustment
1.02%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
Total received
$4K
Payment records
179
By payment type
Food and Beverage$4K
Top paying entities
Food and Beverage$4K
REFERRAL NETWORK
Where Daniel Kreutz's patients come from & go
Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 2 inbound referrers · 7 outbound destinations.
Receives referrals from
Inbound — who sends patients here
| Physician | Patients | Visits |
|---|---|---|
| Jean-Pierre Phancao Diagnostic Radiology · Novato, CA | 25 | 64 |
| BANNER BAYWOOD MEDICAL CENTER | 17 | 30 |
Refers patients to
Outbound — where patients go next
| Physician | Patients | Visits |
|---|---|---|
| Sonora Quest Laboratories Llc Clinical Laboratory · Phoenix, AZ | 194 | 674 |
| Laboratory Corporation Of America Clinical Laboratory · Phoenix, AZ | 35 | 56 |
| Betsy Holland Diagnostic Radiology · Greenbrae, CA | 25 | 53 |
| Ralph Bennett Rheumatology · Mesa, AZ | 19 | 26 |
| BANNER BAYWOOD MEDICAL CENTER | 17 | 38 |
| BANNER DESERT MEDICAL CENTER | 13 | 37 |
| CRESCENDO BIOSCIENCE, INC | 11 | 17 |
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
CROSS-REFERENCE